Shangpin China signs a contract with Meibao Group

Shangpin China Specialty Website construction On August 17, 2017, Shangpin China signed a contract with Meibao Group.

Meibao Group is a new life science enterprise group benefiting the world. It has a wealth of worldwide intellectual property rights. It is the foundation of MEBO/MEBT, the world's regenerative medical technology for burns, wounds and ulcers. It is the economic leader to realize the President's national policy of "developing drugs to regenerate injured organs", and the engine of the regenerative life industry chain, It is a guiding enterprise for human beings to enter the new economic world of regenerative life.

Meibao Group was founded in 1987, formerly known as Beijing Guangming Institute of Burns, Wounds and Ulcers of Traditional Chinese Medicine founded by Dr. Xu Rongxiang and Dr. Li Li. In 1988, the MEBO invented by Xu Rongxiang was granted the new drug certificate by the Ministry of Health of China, and became the first new Chinese medicine approved after the implementation of the Drug Administration Law of China in 1984. The drug and MEBT/MEBO is one of the ten medical technologies popularized by the Ministry of Health throughout the country in the Eighth Five Year Plan.

Meibao Group has two headquarters in China and the United States. It has many transnational burn, wound and ulcer, skin regeneration medicine and medical enterprises in the United States, China, Thailand, India, Malaysia and other countries. It has more than ten series of renewable products with independent intellectual property rights, such as drugs, health products, nutritional food, beauty and skin care products, medical devices and so on. In more than 70 countries, more than 200000 doctors have used Mayfair's technologies and products in more than 20 fields, cured more than 40 million patients with burns, wounds and ulcers, and achieved in situ regeneration and recovery of large area deep burns, diabetic ulcers, distal phalanx amputations, open and defective wounds, lower limb ulcers, deep bedsores and other injured organs.

Meibao Group has more than 40 international invention patents in China, the United States, Europe, Japan and other countries and regions, including potential regenerative cells and their cultivation methods, and core organ regeneration patents such as repairing and regenerating physiological tissues and functional organs through in vivo and in situ stem cell culture. The Science of Human Regeneration and Recovery, Burn Regenerative Medicine and Therapy, Blue Book of Burn Medical Technology and the Complete Book of Burn Treatment written by Xu Rongxiang, the founder of Mayfair, were all included in the National Library of Medicine of the United States; The English version of Burns Regenerative Medicine and Therapy, published by the Swiss Karger Press, has been collected by Harvard University, Princeton University, Massachusetts Institute of Technology and other top universities in the world.

Meibao has an international basic and clinical research center, including Beijing Meibao Institute of Burns, Wounds and Ulcers, Beijing Rongxiang Institute of Regenerative Medicine, American Clinical Research Center and other research bases. After the death of founder Dr. Xu Rongxiang, the new chairman of the Board of Directors Xu Peng led Mayfair to expand a series of international scientific research, enterprise and social platforms: joined the Clinton Global Initiative and implemented the Mayfair Initiative "Regenerative Medical Technology Physician Training", which benefited 20000 Chinese doctors; Joined the United Nations "Every woman, every child" Chinese partner network; Cooperate with the Los Angeles County Health Bureau to plan "regenerative medical technology training" in the Los Angeles health system; The "Xu Rongxiang Regeneration Treatment Center" was established in cooperation with Harvard Medical School; The "Xu Rongxiang Center for Regenerative Life Science" was established in the Davis Institute for the Elderly at the University of Southern California; It was named "Xu Rongxiang University of Health and Public Service" and "Xu Rongxiang Biological Science Innovation Center" of Los Angeles State University. Mayfair began to carry out international cooperation in many aspects and at many levels, to carry out research on the regeneration and recovery of human injured organs, clinical promotion and application, as well as the cultivation of regeneration science talents and social leaders. At the same time, it also launched the Xu Rongxiang Foundation of the United States and the Xu Rongxiang Regeneration Life Public Welfare Fund of the China Red Foundation, which actively played an important role in maintaining international health affairs through another channel.

Mayfair is not only a company, but also a mission oriented enterprise "striving for human life", and a scientific and technological cluster for the benefit of mankind. Xu Rongxiang, the founder, has made historic contributions to human society in the field of burn treatment and regenerative science in the world, laid a solid foundation for the extensive clinical application of human injured organ regeneration, and provided a new direction for the development of regenerative life science in the world. After his death, US President Barack Obama, former President Clinton, George H.W. Bush and other dignitaries sent letters of condolence; Special adjournment of the Los Angeles Sheriff's Assembly; Times Square, New York, commemorated "Dr. Xu Rongxiang, a Chinese scientist - the father of human organ regeneration" for 4 consecutive days; Xu Rongxiang, a Chinese doctor, appeared on the celebrity wall of Harvard Medical School for the first time.